ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
09 Mar 2020 08:16

KT&G: Where There Is Smoke, There May Be Fire

Recent press in Korea has highlighted that the Financial Supervisory Service (FSS) investigation into alleged accounting fraud at KT&G...

Logo
266 Views
Share
28 Feb 2020 08:27

Samsung C&T & Electronics Price Coupling Issue Amid New 3-Yr Shareholder Return Policy

Samsung C&T unveiled a new shareholder return policy for the next three years, FY20~FY22. It said that it would give out 60~70% of the dividend...

Logo
312 Views
Share
25 Feb 2020 17:36

Korea - Shorts Increase on Samsung Common and Pref Shares

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 21 February...

Logo
255 Views
Share
18 Feb 2020 17:44

Korea - AmoreCorp, LotteChem, KMW, Helixmith Shorts Increase; Covering on Shinhan, Semco, Samsung

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 14 February...

Logo
328 Views
Share
bullishSamsung C&T
14 Feb 2020 07:01

LJY's Drug Abuse Allegations on Samsung C&T Synthetic Stub Trade

Samsung family member is again at the center of attention for drug abuse allegations. Last year, it was Lee Bu-jin, Hotel Silla CEO. This time, her...

Logo
349 Views
Share
x